Superiority of dual IDO1/TDO2 inhibition versus IDO1 selective inhibition in reducing immunosuppressive KYN levels in tumors co-expressing IDO1 and TDO2

被引：0
|
作者：
Lotz-Jenne, Carina [1 ]
Cren, Sylvaine [1 ]
Joesch, Christoph [1 ]
Ackerknecht, Sabine [1 ]
Brandes, Jennifer [1 ]
Moebs, Claire [1 ]
Hartl, Dominik [1 ]
Hartrampf, Felix [1 ]
Guerry, Philippe [1 ]
Pothier, Julien [1 ]
Chavanton-Arpel, Alexia [1 ]
机构：
[1] Idorsia Pharmaceut Ltd, Allschwil, Switzerland
来源：
CANCER IMMUNOLOGY RESEARCH | 2022年 / 10卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B66
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Superiority of dual IDO1/TDO2 inhibition versus IDO1 selective inhibition in reducing immunosuppressive KYN levels in tumors co-expressing IDO1 and TDO2
    Lotz-Jenne, Carina
    Cren, Sylvaine
    Joesch, Christoph
    Ackerknecht, Sabine
    Brandes, Jennifer
    Moebs, Claire
    Hartl, Dominik
    Hartrampf, Felix
    Guerry, Philippe
    Pothier, Julien
    Chavanton-Arpel, Alexia
    CANCER RESEARCH, 2023, 83 (07)
  • [2] On the non-redundant roles of TDO2 and IDO1
    Puccetti, Paolo
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [3] Treatment of IDO1 and TDO2 positive tumors with a kynurenine-degrading enzyme: A highly differentiated approach from IDO1 inhibition
    Coma, Silvia
    Cavanaugh, Jillian
    Nolan, James
    Tchaicha, Jeremy
    McGovern, Karen
    Stone, Everett
    Blazeck, John
    Lamb, Candice
    Georgiou, George
    Manfredi, Mark G.
    Zhang, Michelle
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [4] Characterization of IDO1 and TDO2 in pediatric central nervous system tumors
    Lauing, Kristen
    Lulla, Rishi
    Zhai, Lijie
    Hashizume, Rintaro
    Fangusaro, Jason
    Wainwright, Derek A.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [5] Essential roles of the expression of IDO1 and TDO2 in Bladder Cancer
    Pham, Thang Q.
    Nguyen, Tu T.
    Nguyen, Quyen T.
    Luu, Tung D.
    Pham, Diem T.
    Bui, Tam T.
    Duong, Tu T.
    Phan, Thu D.
    Ngo, Dat Q.
    CANCER SCIENCE, 2023, 114 : 1965 - 1965
  • [6] In silico discovery and therapeutic potential of IDO1 and TDO2 inhibitors
    Jernigan, Finith E.
    Sun, Lijun
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (12) : 1309 - 1311
  • [7] Small molecule modulators to understand the role of IDO1 and TDO2 in cancer
    Garapaty, Shivani Rao
    Sivanandhan, Dhanalakshmi
    Seerapu, Guru Pavan Kumar
    Naidu, Surendra
    Chakelam, Shalini
    Nagaraj, Pradeep
    Das, Reshma
    Vadivelu, Saravanan
    Iyer, Pravin
    Mulakala, Chandrika
    Murugan, Kannan
    Mondal, Somnath
    Gautam, Anjali
    Kandan, Saravanan
    Thakur, Manish Kumar
    Rajagopal, Sridharan
    Rajagopal, Sriram
    CANCER RESEARCH, 2017, 77
  • [8] Comprehensive analyzing the expression of IDO1 and TDO2 in bladder cancer.
    Quoc Thang Pham
    Thanh Tu Nguyen
    Thao Quyen Nguyen
    Duc Tung Luu
    Thi Nhu Diem Pham
    Thi Thanh Tam Bui
    Thanh Tu Duong
    Dang Anh Thu Phan
    Quoc Dat Ngo
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation
    Imbeault, Sophie
    Goiny, Michel
    Liu, Xicong
    Erhardt, Sophie
    ACTA NEUROPSYCHIATRICA, 2020, 32 (01): : 43 - 53
  • [10] Novel inhibitors of human IDO1 and TDO
    Banerjee, Monali
    Middya, Sandip
    Shrivastava, Ritesh
    Raina, Sushil
    Yadav, Dharmendra
    Singh, Satveer
    Manna, Anindita
    Chakraborty, Debjani
    Surya, Arjun
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
12345